Actual Medicinal Product (AMP) Clobazam 20mg tablets (Alliance Healthcare (Distribution) Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No stability data in MCAs available but no theoretical concerns with product.
Anecdotal reports of use in MCAs for up to 4 weeks (low quality evidence). - Provenance
-
This recommendation is based on the products Frisium 10mg tablets (Atnahs Pharma UK Ltd) and Clobazam 20mg tablets (Brown & Burk UK Ltd).
- Generic
- Clobazam
- Formulation
- Clobazam 20mg tablets
-
Clobazam
-
Clobazam 20mg tablets
-
Clobazam 20mg tablets (Alliance Healthcare (Distribution) Ltd)
-
-